Krystal Biotech, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Krystal Biotech, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2023.
  • Krystal Biotech, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $10.6M, a 618% increase year-over-year.
  • Krystal Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $203M, a 474% increase from 2022.
  • Krystal Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $35.3M, a 89.8% decline from 2021.
  • Krystal Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $348M, a 195% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $203M +$167M +474% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 $35.3M -$312M -89.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 $348M +$230M +195% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $118M +$10.5M +9.76% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $108M +$33.7M +45.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 $73.8M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.